LifeSpan, Pfizer to Co-develop Automated Pathology System

Mar 03, 2005

NEW YORK, March 3 (GenomeWeb News) - LifeSpan BioSciences and Pfizer will co-develop an automated tissue pathology-analysis system for use in preclinical studies, the companies said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Sequencing of Circulating Tumor DNA Detects Early Cancers
LabCorp Prices $1.2B Senior Notes Offering
Monsanto Licenses ToolGen CRISPR Technology
Curetis Posts 9 Percent Drop in H1 Revenues
PerkinElmer Inks $200M Loan Agreement
Agilent Technologies Q3 Revenues Up 7 Percent

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

Main menu